Hongtao Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hongtao Liu has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Fan Yang
Shengjing Hospital of China Medical University, Shenyang, China
2 shared publications- Fan Yang
Department of Anesthesiology, Shengjing Hospital of China Medical University, Shenyang, China
2 shared publications - Hai Zhao
Surgical Skills Training Laboratory, Clinical Practice Teaching Center, Shenyang Medical College, Shenyang, China
2 shared publications Xiuying Wu
Shengjing Hospital of China Medical University, Shenyang, China
2 shared publications- Xiuying Wu
Department of Anesthesiology, Shengjing Hospital of China Medical University, 36 Sanhao Street, Heping District, Shenyang 110004, China
2 shared publications Yangyang Shan
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
2 shared publications
Latest Publications
- 24 September 2021
- Published by Elsevier in Brain Research Bulletin
- Vol. 177, 155-163
Manifestations and mechanisms of central nervous system damage caused by SARS-CoV-2
- 24 September 2021
- Published by Elsevier in Brain Research Bulletin
- Vol. 177, 155-163
Manifestations and mechanisms of central nervous system damage caused by SARS-CoV-2
- 1 November 2020
- Published by Elsevier in Brain Research Bulletin
- Vol. 164, 37-44
Research progress and treatment strategies for anesthetic neurotoxicity
- 1 November 2020
- Published by Elsevier in Brain Research Bulletin
- Vol. 164, 37-44
Research progress and treatment strategies for anesthetic neurotoxicity
- 1 February 2020
- Published by Elsevier in Life Sciences
- Vol. 242, 117151
Hemin treatment protects neonatal rats from sevoflurane-induced neurotoxicity via the phosphoinositide 3-kinase/Akt pathway
- 1 February 2020
- Published by Elsevier in Life Sciences
- Vol. 242, 117151
Hemin treatment protects neonatal rats from sevoflurane-induced neurotoxicity via the phosphoinositide 3-kinase/Akt pathway
- Open Access
- 28 May 2019
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 13, 537
The Neuroprotective Effect of Hemin and the Related Mechanism in Sevoflurane Exposed Neonatal Rats
Background: Many studies have reported that sevoflurane can increase neuronal apoptosis and result in cognitive deficits in rodents. Although neurotoxicity may be associated with mitochondrial dysfunction and oxidative stress, the exact mechanism remains unclear. In order to evaluate potential treatment therapies, we studied the effects of hemin on neurotoxicity of neonatal rat sevoflurane exposure. Methods: Postnatal day (P) seven rats were assigned randomly to four groups; (1) group C: non-anesthesia, (2) group H: intraperitoneal hemin (50 mg kg−1) treatment on days 5 and 6, (3) group S: 3% sevoflurane exposure for 4 h, and (4) group SH: hemin treatment + sevoflurane exposure. The expression of neuroglobin in neonatal hippocampus was determined by western blot and immunohistochemistry. Neuroglobin was localized by immunofluorescence. Western blot for the expression of cleaved caspase-3 and TUNEL were used to detect neonatal hippocampal apoptosis, and cytochrome c was used to evaluate mitochondrial function. Drp-1 and Mfn-2 immunoblotting were used to assess mitochondrial dynamics. The Morris water maze test was performed to detect cognitive function in the rats on P30. Results: Exposure to sevoflurane increased the expression of cleaved caspase-3, cytochrome c, and Drp1 in the neonatal hippocampus and resulted in cognitive deficiency but decreased expression of Mfn2. Hemin reduced apoptosis, improved mitochondrial dynamics and ameliorated the cognitive impairment caused by sevoflurane exposure. Conclusion: Hemin reduced neuronal apoptosis, improved mitochondrial dynamics and protected against cognitive deficits induced by sevoflurane in neonatal rats. This neuroprotective effect may be achieved by increasing the expression of neuroglobin.
- 28 May 2019
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 13, 537
Open AccessThe Neuroprotective Effect of Hemin and the Related Mechanism in Sevoflurane Exposed Neonatal Rats
Background: Many studies have reported that sevoflurane can increase neuronal apoptosis and result in cognitive deficits in rodents. Although neurotoxicity may be associated with mitochondrial dysfunction and oxidative stress, the exact mechanism remains unclear. In order to evaluate potential treatment therapies, we studied the effects of hemin on neurotoxicity of neonatal rat sevoflurane exposure. Methods: Postnatal day (P) seven rats were assigned randomly to four groups; (1) group C: non-anesthesia, (2) group H: intraperitoneal hemin (50 mg kg−1) treatment on days 5 and 6, (3) group S: 3% sevoflurane exposure for 4 h, and (4) group SH: hemin treatment + sevoflurane exposure. The expression of neuroglobin in neonatal hippocampus was determined by western blot and immunohistochemistry. Neuroglobin was localized by immunofluorescence. Western blot for the expression of cleaved caspase-3 and TUNEL were used to detect neonatal hippocampal apoptosis, and cytochrome c was used to evaluate mitochondrial function. Drp-1 and Mfn-2 immunoblotting were used to assess mitochondrial dynamics. The Morris water maze test was performed to detect cognitive function in the rats on P30. Results: Exposure to sevoflurane increased the expression of cleaved caspase-3, cytochrome c, and Drp1 in the neonatal hippocampus and resulted in cognitive deficiency but decreased expression of Mfn2. Hemin reduced apoptosis, improved mitochondrial dynamics and ameliorated the cognitive impairment caused by sevoflurane exposure. Conclusion: Hemin reduced neuronal apoptosis, improved mitochondrial dynamics and protected against cognitive deficits induced by sevoflurane in neonatal rats. This neuroprotective effect may be achieved by increasing the expression of neuroglobin.